Tuberculosis and its future in the COVID-19 era: The Pulmonology series 2021.

Migliori, G B; Tiberi, S; García-Basteiro, A L; Duarte, R

Migliori, G B; Tiberi, S; García-Basteiro, A L; Duarte, R.

Afiliación

Migliori GB; Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy. Electronic address: giovannibattista.migliori@icsmaugeri.it.
Tiberi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Division of Infection, Royal London Hospital, Barts Health NHS Trust, London, UK. Electronic address: s.tiberi@qmul.ac.uk.
García-Basteiro AL; ISGlobal, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação Em Saúde de Manhiça, Maputo, Mozambique. Electronic address: alberto.garcia-basteiro@isglobal.org.
Duarte R; Pulmonology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal; Public Health Science and Medical Education Dept, Faculty of Medicine, University of Porto, Porto, Portugal. Electronic address: raquelafduarte@gmail.com.

Pulmonology ; 27(2): 94-96, 2021.

Article en En | MEDLINE | ID: mdl-33272908

Asunto(s)

COVID-19; Neumología; Tuberculosis Resistente a Múltiples Medicamentos; Tuberculosis; Humanos; SARS-CoV-2; Tuberculosis/epidemiología

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tuberculosis / Neumología / Tuberculosis Resistente a Múltiples Medicamentos / COVID-19 Límite: Humans Idioma: En Revista: Pulmonology Año: 2021 Tipo del documento: Article Pais de publicación: España

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google